Skip to content

Study on diagnosis of lung cancer and other diseases by exhale breath analysis based on gas chromatography technology

Study on diagnosis of lung cancer and other diseases by exhale breath analysis based on gas chromatography technology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063064
Enrollment
Unknown
Registered
2022-08-30
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Gold Standard:1. Pathological diagnosis is lung cancer, lung cancer group
2. Pathological diagnosis is non-lung cancer, benign space occupying group
3. There is no pathological diagnosis result and CT shows pulmonary nodule, which is classified as CT lung nodules group
4. CT shows without lung disease was the control grou
Index test:Pattern&#32
screening&#32
and&#32
the&#32
of&#32
detection&#32
model&#32
lung&#32

Sponsors

Sichuan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Subjects with lung space occupying: First diagnosed in Sichuan Cancer Hospital because of lung space occupying; Physical examination subjects: healthy subjects who underwent CT physical examination screening; 2. Age: between 18 and 75 years old; 3. No gender limitation; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from other malignant tumors; 2. Patients with severe bronchial asthma; 3. Patients with severe liver function damage; 4. Patients with severe nephropathy; 5. Patients in the acute stage of inflammation; 6. Subjects who were considered by the investigator to be unsuitable for participating in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Exhale volatile organic compound (VOC);

Countries

China

Contacts

Public ContactLi Qiang

Thoracic Surgery Center of Sichuan Cancer Hospital

liqiang1907@VIP.Sina.com+86 18908178887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026